GALDERMA PHASE III DATA PUBLISHED IN THE NEW ENGLAND JOURNAL OF MEDICINE: FULL OLYMPIA 2 TRIAL RESULTS DEMONSTRATE NEMOLIZUMAB'S RAPID ONSET OF ACTION IN PRURIGO NODULARIS PATIENTS
GALDERMA PHASE III DATA PUBLISHED IN the NEW ENGLAND JOURNAL OF MEDICINE: full OLYMPIA 2 TRIAL RESULTS DEMONSTRATE NEMOLIZUMAB’S RAPID ONSET OF ACTION iN PRURIGO NODULARIS PATIENTS The phase III OLYMPIA 2 trial in patients with prurigo nodularis met all primary and key secondary endpoints, showing nemoliz...